Stock Events

Stock Events

ANI Pharmaceuticals 

$76.50
28
-$2.03-2.58% 11:13 Today

Statistics

Day High
78.61
Day Low
78.41
52W High
99.5
52W Low
62.61
Volume
9,264
Avg. Volume
-
Mkt Cap
1.79B
P/E Ratio
20.99
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
1.09
1.41
1.73
2.05
Expected EPS
2.042625
Actual EPS
N/A

Financials

8.74%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
883.37MRevenue
77.18MNet Income

Analyst Ratings

91.00Average Price Target
The highest estimate is 91.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ANIP. It's not an investment recommendation.
NVIDIA
8
NVDA
AMD
7
AMD
Microsoft
6
MSFT
Amazon
6
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.37B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, directly competing with ANI Pharmaceuticals in the generics market.
Perrigo Company
PRGO
Mkt Cap1.41B
Perrigo Company plc specializes in over-the-counter health and wellness products, competing with ANI Pharmaceuticals in the area of generic pharmaceuticals.
Dr. Reddy`s Laboratories
RDY
Mkt Cap10.98B
Dr. Reddy’s Laboratories is an Indian multinational pharmaceutical company that produces generic drugs, competing with ANI Pharmaceuticals in various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson is a diversified healthcare giant that, through its pharmaceutical segment, competes with ANI Pharmaceuticals in both the development and marketing of pharmaceutical products.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie is a research-based biopharmaceutical company whose diverse range of products competes with ANI Pharmaceuticals, especially in specialty therapeutic areas.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a global pharmaceutical corporation with a broad portfolio of products, including generic drugs, that competes with ANI Pharmaceuticals.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. is a global healthcare company that operates in the pharmaceutical sector, competing with ANI Pharmaceuticals in the development and marketing of drugs across various therapeutic areas.

About

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Show more...
CEO
Mr. Nikhil Lalwani
Employees
970
Country
United States
ISIN
US00182C1036

Listings

F
DE
BSFA.F
STU
DE
BSFA.STU
MU
DE
BSFA.MU
XNAS
US
ANIP

0 Comments

Share your thoughts

FAQ

What is ANI Pharmaceuticals stock price today?▼
The current price of ANIP is $76.50 USD — it has decreased by -2.58% in the past 24 hours. Watch ANI Pharmaceuticals stock price performance more closely on the chart.
What is ANI Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ANI Pharmaceuticals stocks are traded under the ticker ANIP.
Is ANI Pharmaceuticals stock price growing?▼
ANIP stock has fallen by -0.85% compared to the previous week, the month change is a -5.07% fall, over the last year ANI Pharmaceuticals has showed a +17.61% increase.
What is ANI Pharmaceuticals market cap?▼
Today ANI Pharmaceuticals has the market capitalization of 1.79B
When is the next ANI Pharmaceuticals earnings date?▼
ANI Pharmaceuticals is going to release the next earnings report on August 12, 2026.
What were ANI Pharmaceuticals earnings last quarter?▼
ANIP earnings for the last quarter are 2.05 USD per share, whereas the estimation was 1.3 USD resulting in a +57.84% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ANI Pharmaceuticals revenue for the last year?▼
ANI Pharmaceuticals revenue for the last year amounts to 883.37M USD.
What is ANI Pharmaceuticals net income for the last year?▼
ANIP net income for the last year is 77.18M USD.
How many employees does ANI Pharmaceuticals have?▼
As of July 24, 2026, the company has 970 employees.
In which sector is ANI Pharmaceuticals located?▼
ANI Pharmaceuticals operates in the Health & Wellness sector.
When did ANI Pharmaceuticals complete a stock split?▼
The last stock split for ANI Pharmaceuticals was on July 18, 2013 with a ratio of 1:6.
Where is ANI Pharmaceuticals headquartered?▼
ANI Pharmaceuticals is headquartered in Baudette, United States.